Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-31T23:22:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-24T23:24:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T23:40:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T23:39:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating the record is currently inaccessible on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-19T22:32:41.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This update does not change the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T21:44:30.000Z thumbnail image

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.